| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |